{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:52:01Z","timestamp":1789570321434,"version":"build-2803163510"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atopic dermatitis (AD) is a chronic, pruritic, immune-mediated inflammatory skin disorder characterized by Th2-dominant immune response, which may contribute to systemic inflammation. Hydrogels, as drug delivery vehicles, demonstrate excellent biocompatibility and superior moisturizing capabilities. Berberine exhibits anti-inflammatory, antibacterial, and immunomodulatory properties. However, the therapeutic efficacy and underlying mechanisms of berberine-loaded hydrogel (BHG) in the management of AD remain insufficiently elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The morphology and structure of the hydrogel were examined using scanning electron microscopy.\n                      <jats:italic>In vitro<\/jats:italic>\n                      biocompatibility of the BHG was assessed via the CCK-8 assay and hemolysis testing.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , an AD model was induced in mice by topical application of DNFB to the shaved dorsal skin. Clinical symptoms, including erythema, edema, and crusting, were monitored, and serum levels of IL-4, IL-13, IgE, and histamine were quantified using ELISA. H&amp;amp;E staining was performed to evaluate epidermal and dermal thickness, while toluidine blue staining was employed to assess mast cell infiltration in the dermis. Immunohistochemical staining was conducted to examine the expression of skin barrier-related proteins, and immunofluorescence staining was utilized to detect reactive oxygen species (ROS) levels in skin tissues. The expression levels of PI3K, AKT, and NF-\u03baB pathway proteins were analyzed by Western blotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The BHG exhibited no adverse effect on HaCaT cell viability and demonstrated effective inhibition of Staphylococcus aureus proliferation. It significantly alleviated dermatological symptoms in AD mice, including erythema, edema, and crusting, while reducing scratching frequency, epidermal thickness, and mast cell infiltration. The formulation suppressed the expression of Th2-associated cytokines, including IL-4, IL-13, TNF-\u03b1, IL-6, and IgE. In the dorsal skin of AD mice, the BHG reduced levels of ROS and malondialdehyde (MDA), while increasing superoxide dismutase (SOD) activity. Furthermore, it enhanced the expression of skin barrier proteins such as filaggrin, occludin, and ZO-1, and downregulated the expression of phosphorylated PI3K, AKT, and NF-\u03baB (p-PI3K, p-AKT, and p-NF-\u03baB) proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The BHG exhibits favorable biocompatibility and potent antibacterial activity, and is capable of restoring the skin barrier and ameliorating dermatological symptoms in AD mice. Its anti-inflammatory and antioxidant effects may be mediated through modulation of the PI3K\/AKT\/NF-\u03baB signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1740911","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:36:32Z","timestamp":1768973792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A berberine-loaded hydrogel for the treatment of atopic dermatitis through antibacterial activity, inhibition of inflammation and modulation of oxidative stress"],"prefix":"10.3389","volume":"17","author":[{"given":"Ze","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing University of Chinese Medicine","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulinigaer","family":"anwaier","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing University of Chinese Medicine","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Jun","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00003-7","article-title":"Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"13","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.14789\/ejmj.JMJ24-0036-R","article-title":"Mechanisms of itch in atopic dermatitis","volume":"71","author":"Kamata","year":"2025","journal-title":"Juntendo Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1111\/1346-8138.17544","article-title":"English version of clinical practice guidelines for the management of atopic dermatitis 2024","volume":"52","author":"Saeki","year":"2025","journal-title":"J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8077","article-title":"Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review","volume":"38","author":"Shakeri","year":"2024","journal-title":"Phytother Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"155258","DOI":"10.1016\/j.phymed.2023.155258","article-title":"Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"20220169","DOI":"10.1002\/EXP.20220169","article-title":"Progress on quantum dot photocatalysts for biomass valorization","volume":"3","author":"Cao","year":"2023","journal-title":"Explor (Beijing)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"26003","DOI":"10.1038\/s41598-025-11226-0","article-title":"Mechanistic studies on the effect of berberine on methicillin-resistant Staphylococcus aureus drug resistance through modulation of wall teichoteic acid","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1085013","article-title":"Antidiabetic activity of Berberis brandisiana is possibly mediated through modulation of insulin signaling pathway, inflammatory cytokines and adipocytokines in high fat diet and streptozotocin-administered rats","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S401293","article-title":"Berberine alleviates acute lung injury in septic mice by modulating treg\/th17 homeostasis and downregulating NF-kappaB signaling","volume":"17","author":"Chen","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23434","article-title":"Neuroprotective potential of berberine against acetamiprid induced toxicity in rats: Implication of oxidative stress, mitochondrial alterations, and structural changes in brain regions","volume":"37","author":"Phogat","year":"2023","journal-title":"J Biochem Mol Toxicol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"108910","DOI":"10.1016\/j.fsi.2023.108910","article-title":"Dietary berberine against intestinal oxidative stress, inflammation response, and microbiota disturbance caused by chronic copper exposure in freshwater grouper (Acrossocheilus fasciatus)","volume":"139","author":"Wang","year":"2023","journal-title":"Fish Shellfish Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"154343","DOI":"10.1016\/j.phymed.2022.154343","article-title":"Exploring the mechanism of berberine-mediated T(fh) cell immunosuppression","volume":"105","author":"Vita","year":"2022","journal-title":"Phytomedicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12864","article-title":"Use of emollients in atopic dermatitis","volume":"29","author":"Ng","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/ijms25041982","article-title":"Hydrogel-based skin regeneration","volume":"25","author":"Arabpour","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"20230019","DOI":"10.1002\/EXP.20230019","article-title":"Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy","volume":"4","author":"Feng","year":"2024","journal-title":"Explor (Beijing)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.22203\/eCM.v049a02","article-title":"The eve of a historic breakthrough in the realm of human pluripotent stem cell-derived haematopoietic stem cells","volume":"49","author":"Chen","year":"2025","journal-title":"Eur Cell Mater"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2022.01.014","article-title":"The novel KLF4\/BIG1 regulates LPS-mediated neuro-inflammation and migration in BV2 cells via PI3K\/akt\/NF-kB signaling pathway","volume":"488","author":"You","year":"2022","journal-title":"Neuroscience"},{"key":"B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13020-025-01125-x","article-title":"Yangke powder alleviates OVA-induced allergic asthma by inhibiting the PI3K\/AKT\/NF-kappaB signaling pathway","volume":"20","author":"Li","year":"2025","journal-title":"Chin Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-kappaB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.04.005","article-title":"Assessment of treatment-relevant immune biomarkers in psoriasis and atopic dermatitis: toward personalized medicine in dermatology","volume":"143","author":"Mortlock","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2024.05.001","article-title":"Topical therapy for atopic dermatitis: what is new and the new paradigm","volume":"42","author":"Buethe","year":"2024","journal-title":"Dermatol Clin"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304110-00005","article-title":"Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders","volume":"4","author":"Loden","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.2174\/138161208784007653","article-title":"Scope and limitations of the co-drug approach to topical drug delivery","volume":"14","author":"Lau","year":"2008","journal-title":"Curr Pharm Des"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e09346","DOI":"10.1002\/adma.202509346","article-title":"Polyphenol oxidase-like nanozymes","volume":"37","author":"Gu","year":"2025","journal-title":"Adv Mater"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2307337","DOI":"10.1002\/adma.202307337","article-title":"Co-based nanozymatic profiling: advances spanning chemistry, biomedical, and environmental sciences","volume":"36","author":"Li","year":"2024","journal-title":"Adv Mater"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e202315031","DOI":"10.1002\/anie.202315031","article-title":"Polyoxometalate-nanozyme-integrated nanomotors (POMotors) for self-propulsion-promoted synergistic photothermal-catalytic tumor therapy","volume":"63","author":"Tang","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"B29","doi-asserted-by":"publisher","first-page":"125949","DOI":"10.1016\/j.ijbiomac.2023.125949","article-title":"Polysaccharide-based hydrogel promotes skin wound repair and research progress on its repair mechanism","volume":"248","author":"Zhang","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B30","article-title":"The importance of vehicle properties to patients with atopic dermatitis","volume":"88","author":"Trookman","year":"2011","journal-title":"Cutis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.03.002","article-title":"Recent progress of collagen, chitosan, alginate and other hydrogels in skin repair and wound dressing applications","volume":"208","author":"Peng","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1940962","article-title":"The IL-4, IL-13 and IL-31 pathways in atopic dermatitis","volume":"17","author":"Dubin","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2020.12.033","article-title":"A basophil-neuronal axis promotes itch","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2021.04.007","article-title":"Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents","volume":"102","author":"Luger","year":"2021","journal-title":"J Dermatol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.10.019","article-title":"Genetic and immunological pathogenesis of atopic dermatitis","volume":"144","author":"Schuler","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"Brown","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.19125","article-title":"Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review","volume":"37","author":"Demessant-Flavigny","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.567090","article-title":"Colonization with staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown","volume":"11","author":"Ogonowska","year":"2020","journal-title":"Front Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2667","article-title":"Variation in Staphylococcus aureus Colonization in Relation to Disease Severity in Adults with Atopic Dermatitis during a Five-month Follow-up","volume":"97","author":"Alsterholm","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00424-016-1903-9","article-title":"Tight junctions in skin inflammation","volume":"469","author":"Basler","year":"2017","journal-title":"Pflugers Arch"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.jid.5700940","article-title":"Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation","volume":"128","author":"Purwar","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00751.x","article-title":"Antioxidant activity, lipid peroxidation and skin diseases. What's new","volume":"17","author":"Briganti","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/antiox9030196","article-title":"Oxidative stress and atopic dermatitis","volume":"9","author":"Bertino","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.3390\/ijms26094210","article-title":"Role of oxidative stress and antioxidants in the course of atopic dermatitis","volume":"26","author":"Kvedariene","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1217165","article-title":"Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease","volume":"14","author":"Sahoo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3390\/cells12121671","article-title":"The PI3K-akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using natural and synthetic compounds","volume":"12","author":"Roy","year":"2023","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.1016\/j.pscia.2024.100037","article-title":"Current status and research progress of oncolytic virus","volume":"2","author":"Chen","year":"2024","journal-title":"Pharm Sci Advances"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.3390\/molecules26113298","article-title":"Effects of deacetylasperulosidic acid on atopic dermatitis through modulating immune balance and skin barrier function in haCaT, HMC-1, and EOL-1 cells","volume":"26","author":"Oh","year":"2021","journal-title":"Molecules"},{"key":"B53","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/j.pscia.2025.100077","article-title":"Study on the CHJ01 antitumor activity and mechanism via targeting sphingosine kinase 1 in A549 cells","volume":"3","author":"Liu","year":"2025","journal-title":"Pharm Sci Advances"},{"key":"B54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/039463200702000107","article-title":"Nuclear factor kappaB activity is increased in peripheral blood mononuclear cells of children affected by atopic and non-atopic eczema","volume":"20","author":"Angelini","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B55","article-title":"The characterization and clinical significance of PI3K\/Akt signaling pathway activation in the peripheral T cells of pediatric patients with atopic dermatitis","volume":"10","author":"Xiao","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jep.2018.04.016","article-title":"Jageum-Jung improves 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice and suppresses pro-inflammatory chemokine production by inhibiting TNF-alpha\/IFN-gamma-induced STAT-1 and NFkappaB signaling in HaCaT cells","volume":"221","author":"Yang","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.4833","article-title":"Schizonepeta tenuifolia inhibits the development of atopic dermatitis in mice","volume":"27","author":"Choi","year":"2013","journal-title":"Phytother Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","article-title":"Guidelines of care for the management of atopic dermatitis in adults with topical therapies","volume":"89","author":"Sidbury","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.144","article-title":"Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis","volume":"131","author":"Hatano","year":"2011","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1740911\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:36:34Z","timestamp":1768973794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1740911\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2026.1740911"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1740911","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1740911"}}